ArticleCost effectiveness and resource allocation : C/E2015

Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK.

Yogesh Suresh Punekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.